May 08, 2019 / 05:00PM GMT
Sung Lee - Gilead Sciences, Inc. - VP of IR
Okay. Well thank you, everyone, for being here at our Annual Shareholder Meeting. My name is Sung Lee of Investor Relations. We'll get started very soon here. I'd like to turn over the mic over to our Chairman and CEO, Daniel O'Day.
Daniel O'Day - Gilead Sciences, Inc. - Chairman & CEO
Great. Thank you, Sung, and good morning, everybody. I'm Daniel O'Day, Chairman of the Board and Chief Executive Officer of Gilead Sciences. And I'm very, very pleased to welcome you to today's Gilead's 2019 Annual Meeting of Stockholders.
Before I call the meeting to order, I'd like to introduce you to some of the members of the Gilead team sitting up front here and some of the members of the Board of Directors as well. So first, starting with the Board, we have John Cogan, our Lead Independent Director; Jacqueline Barton; Kelly Kramer; Richard Whitley; Gayle Wilson; and Per Wold-Olsen. Thank you for being here. We also have several members of our leadership team here this morning. We have Robin Washington
Gilead Sciences Inc Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot